As of 2024-12-12, the EV/EBITDA ratio of LungLife AI Inc (LLAI.L) is -0.14. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LLAI.L's latest enterprise value is 0.60 mil GBP. LLAI.L's TTM EBITDA according to its financial statements is -4.32 mil GBP. Dividing these 2 quantities gives us the above LLAI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 17.4x | 16.0x |
| Forward P/E multiples | 15.7x - 21.4x | 15.8x |
| Fair Price | (196.70) - (217.94) | (198.77) |
| Upside | -2170.5% - -2394.2% | -2192.3% |
| Date | EV/EBITDA |
| 2024-11-29 | -0.00 |
| 2024-11-28 | -0.00 |
| 2024-11-27 | 0.01 |
| 2024-11-26 | 0.01 |
| 2024-11-25 | 0.01 |
| 2024-11-22 | 0.01 |
| 2024-11-21 | 0.03 |
| 2024-11-20 | 0.03 |
| 2024-11-19 | 0.03 |
| 2024-11-18 | 0.06 |
| 2024-11-15 | 0.06 |
| 2024-11-14 | 0.04 |
| 2024-11-13 | 0.04 |
| 2024-11-12 | 0.04 |
| 2024-11-11 | 0.04 |
| 2024-11-08 | 0.04 |
| 2024-11-07 | 0.04 |
| 2024-11-06 | 0.04 |
| 2024-11-05 | 0.04 |
| 2024-11-04 | 0.04 |
| 2024-11-01 | 0.04 |
| 2024-10-31 | 0.04 |
| 2024-10-30 | 0.01 |
| 2024-10-29 | 0.04 |
| 2024-10-28 | -0.03 |
| 2024-10-25 | -0.03 |
| 2024-10-24 | -0.02 |
| 2024-10-23 | -0.02 |
| 2024-10-22 | -0.06 |
| 2024-10-21 | -0.06 |
| 2024-10-18 | -0.06 |
| 2024-10-17 | -0.06 |
| 2024-10-16 | -0.06 |
| 2024-10-15 | -0.04 |
| 2024-10-14 | 0.01 |
| 2024-10-11 | -0.08 |
| 2024-10-10 | -0.08 |
| 2024-10-09 | -0.07 |
| 2024-10-08 | -0.12 |
| 2024-10-07 | -0.06 |
| 2024-10-04 | -0.12 |
| 2024-10-03 | -0.11 |
| 2024-10-02 | -0.11 |
| 2024-10-01 | -0.14 |
| 2024-09-30 | -0.14 |
| 2024-09-27 | -0.14 |
| 2024-09-26 | -0.14 |
| 2024-09-25 | -0.14 |
| 2024-09-24 | -0.15 |
| 2024-09-23 | -0.15 |